Ulerythema Clinical Presentation

1. Burnett JW, Schwartz MF, Berberian BJ. Ulerythema ophryogenes with multiple congenital anomalies. J Am Acad Dermatol. 1988 Feb. 18(2 Pt 2):437-40. [QxMD MEDLINE Link].

2. Gómez Centeno P, Rosón E, Peteiro C, Mercedes Pereiro M, Toribio J. Rubinstein--Taybi syndrome and ulerythema ophryogenes in a 9-year-old boy. Pediatr Dermatol. 1999 Mar-Apr. 16(2):134-6. [QxMD MEDLINE Link].

3. Snell JA, Mallory SB. Ulerythema ophryogenes in Noonan syndrome. Pediatr Dermatol. 1990 Mar. 7(1):77-8. [QxMD MEDLINE Link].

4. Morton CM, Bhate C, Janniger CK, Schwartz RA. Ulerythema ophryogenes: updates and insights. Cutis. 2014 Feb. 93(2):83-7. [QxMD MEDLINE Link].

5. Couselo-Rodríguez C, Batalla-Cebey A, Álvarez-Álvarez C, Flórez Á. [Ulerythema ophryogenes as an entity associated with 18p- syndrome in a pediatric patient]. Arch Argent Pediatr. 2021 Dec. 119 (6):e636-e638. [QxMD MEDLINE Link].

6. Luria RB, Conologue T. Atrophoderma vermiculatum: a case report and review of the literature on keratosis pilaris atrophicans. Cutis. 2009 Feb. 83(2):83-6. [QxMD MEDLINE Link].

7. Turegano MM, Sperling LC. Lichenoid folliculitis: A unifying concept. J Cutan Pathol. 2017 Mar 26. [QxMD MEDLINE Link].

8. Guidry JA, Rees A, Chan AJ, Shuja F, Hsu S. Ulerythema ophryogenes and Noonan syndrome. Dermatol Online J. 2013 Feb 15. 19(2):14. [QxMD MEDLINE Link].

9. Layton AM, Cunliffe WJ. A case of ulerythema ophryogenes responding to isotretinoin. Br J Dermatol. 1993 Nov. 129(5):645-6. [QxMD MEDLINE Link].

10. Handrick C, Alster TS. Laser treatment of atrophoderma vermiculata. J Am Acad Dermatol. 2001 Apr. 44(4):693-5. [QxMD MEDLINE Link].

11. Rodriguez-Lojo R, Pozo JD, Barja JM, et al. Keratosis pilaris atrophicans: treatment with intense pulsed light in four patients. J Cosmet Laser Ther. 2010 Aug. 12(4):188-90. [QxMD MEDLINE Link].

12. Alcántara González J, Boixeda P, Truchuelo Díez MT, Fleta Asín B. Keratosis pilaris rubra and keratosis pilaris atrophicans faciei treated with pulsed dye laser: report of 10 cases. J Eur Acad Dermatol Venereol. 2011 Jun. 25(6):710-4. [QxMD MEDLINE Link].

13. Kechichian E, Jabbour S, El Hachem L, Tomb R, Helou J. Light and Laser Treatments for Keratosis Pilaris: A Systematic Review. Dermatol Surg. 2020 Nov. 46 (11):1397-1402. [QxMD MEDLINE Link].

14. Carvalho CA, Carvalho AV, Kiss A, Paskulin G, Götze FM. Keratosis pilaris and ulerythema ophryogenes in a woman with monosomy of the short arm of chromosome 18. An Bras Dermatol. 2011 Jul-Aug. 86(4 Suppl 1):S42-5. [QxMD MEDLINE Link].

15. Liakou AI, Esteves de Carvalho AV, Nazarenko LP. Trias of keratosis pilaris, ulerythema ophryogenes and 18p monosomy: Zouboulis syndrome. J Dermatol. 2014 May. 41(5):371-6. [QxMD MEDLINE Link].

16. Siegel DH, Mann JA, Krol AL, Rauen KA. Dermatological phenotype in Costello syndrome: consequences of Ras dysregulation in development. Br J Dermatol. 2012 Mar. 166(3):601-7. [QxMD MEDLINE Link].

17. Bessis D, Morice-Picard F, Bourrat E, et al. Dermatological manifestations in cardiofaciocutaneous syndrome: a prospective multicentric study of 45 mutation-positive patients. Br J Dermatol. 2019 Jan. 180 (1):172-180. [QxMD MEDLINE Link].

18. Nazarenko SA, Ostroverkhova NV, Vasiljeva EO, Nazarenko LP, Puzyrev VP, Malet P, et al. Keratosis pilaris and ulerythema ophryogenes associated with an 18p deletion caused by a Y/18 translocation. Am J Med Genet. 1999 Jul 16. 85(2):179-82. [QxMD MEDLINE Link].

19. Zouboulis CC, Stratakis CA, Rinck G, Wegner RD, Gollnick H, Orfanos CE. Ulerythema ophryogenes and keratosis pilaris in a child with monosomy 18p. Pediatr Dermatol. 1994 Jun. 11(2):172-5. [QxMD MEDLINE Link].

20. Zouboulis CC, Stratakis CA, Gollnick HP, Orfanos CE. Keratosis pilaris/ulerythema ophryogenes and 18p deletion: is it possible that the LAMA1 gene is involved?. J Med Genet. 2001 Feb. 38(2):127-8. [QxMD MEDLINE Link].

21. Klein OD, Cotter PD, Schmidt AM, et al. Interstitial deletion of chromosome 12q: genotype-phenotype correlation of two patients utilizing array comparative genomic hybridization. Am J Med Genet A. 2005 Nov 1. 138(4):349-54. [QxMD MEDLINE Link].

22. Li K, Ann Thomas M, Haber RM. Ulerythema ophryogenes, a rarely reported cutaneous manifestation of noonan syndrome: case report and review of the literature. J Cutan Med Surg. 2013 May-Jun. 17(3):212-8. [QxMD MEDLINE Link].

23. Klar J, Schuster J, Khan TN, Jameel M, Mäbert K, Forsberg L, et al. Whole exome sequencing identifies LRP1 as a pathogenic gene in autosomal recessive keratosis pilaris atrophicans. J Med Genet. 2015 Sep. 52 (9):599-606. [QxMD MEDLINE Link].

24. Lee YC, Son SJ, Han TY, Lee JH. A Case of Atrophoderma Vermiculatum Showing a Good Response to Topical Tretinoin. Ann Dermatol. 2018 Feb. 30 (1):116-118. [QxMD MEDLINE Link].

25. Volks N, Fölster-Holst R. Erythromelanosis follicularis faciei--a variant of keratosis pilaris?. J Dtsch Dermatol Ges. 2015 Jan. 13 (1):51-4. [QxMD MEDLINE Link].

26. Arif T, Adil M, Amin SS, Tahseen M, Dorjay K, Mohtashim M, et al. Erythromelanosis follicularis faciei et colli: A clinicoepidemiologic study. Pediatr Dermatol. 2018 Jan. 35 (1):e70-e71. [QxMD MEDLINE Link].

27. Hodak E, Amitay-Laish I, Atzmony L, Prag-Naveh H, Yanichkin N, Barzilai A, et al. New insights into folliculotropic mycosis fungoides (FMF): A single-center experience. J Am Acad Dermatol. 2016 May 28. [QxMD MEDLINE Link].

28. Shimizu A, Hattori M, Takeuchi Y, Ishikawa O. Generalized keratosis pilaris-like eruptions in a chronic myelogenous leukemia patient treated with nilotinib. J Dermatol. 2016 Mar 30. [QxMD MEDLINE Link].

29. Quintana Castanedo L, Sánchez Orta A, Maseda Pedrero R, Santos Simarro F, Palomares Bralo M, Feito Rodríguez M, et al. Skin and nails abnormalities in a patient with ZTTK syndrome and a de novo mutation in SON. Pediatr Dermatol. 2020 Feb 11. [QxMD MEDLINE Link].

30. Jerjen R, Sinclair R, Meah N, Bhoyrul B. Ulerythema Ophryogenes Mimicking Frontal Fibrosing Alopecia. Dermatol Surg. 2021 Jul 1. 47 (7):1024-1025. [QxMD MEDLINE Link].

31. Zegarska B, Kallas D, Schwartz RA, Czajkowski R, Uchanska G, Placek W. Graham-Little syndrome. Acta Dermatovenerol Alp Panonica Adriat. 2010 Oct. 19(3):39-42. [QxMD MEDLINE Link].

32. Dajani ZA, Kerns MJ, Mutasim DF. Unilateral keratosis pilaris atrophicans faciei mimicking follicular mucinosis. J Am Acad Dermatol. 2011 May. 64(5):e71-2. [QxMD MEDLINE Link].

Camila K Janniger, MD Clinical Professor of Dermatology, Clinical Associate Professor of Pediatrics, Chief of Pediatric Dermatology, Rutgers New Jersey Medical School

Camila K Janniger, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

Michael J Wells, MD, FAAD Dermatologic/Mohs Surgeon, The Surgery Center at Plano Dermatology

Michael J Wells, MD, FAAD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, Texas Medical Association

Disclosure: Nothing to disclose.

Robert A Schwartz, MD, MPH Professor and Head of Dermatology, Professor of Pathology, Professor of Pediatrics, Professor of Medicine, Rutgers New Jersey Medical School

Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, New York Academy of Medicine, Royal College of Physicians of Edinburgh, Sigma Xi, The Scientific Research Honor Society

Disclosure: Nothing to disclose.

Dirk M Elston, MD Professor and Chairman, Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina College of Medicine

Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology

Disclosure: Nothing to disclose.

James J Nordlund, MD Professor Emeritus, Department of Dermatology, University of Cincinnati College of Medicine

James J Nordlund, MD is a member of the following medical societies: American Academy of Dermatology, Sigma Xi, The Scientific Research Honor Society, Society for Investigative Dermatology

Disclosure: Nothing to disclose.

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous author, Aleksej Kansky, MD, PhD, to the development and writing of this article.

• Print this section
• Print the entire contents of
• Print the entire contents of article